☰

Subburaj Ilangumaran - Publications

Affiliations: 
Université de Sherbrooke, Sherbrooke, Québec, Canada 
Tree Info Similar researchers PubMed Report error

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Nandi M, Ghosh A, Akbari SA, Bobbala D, Boucher MJ, Menendez A, Hoang T, Ilangumaran S, Ramanathan S. IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation. Cancers. 15. PMID 36765626 DOI: 10.3390/cancers15030671  0.593
2022 Kautzman AM, Mobulakani JMF, Marrero Cofino G, Quenum AJI, Cayarga AA, Asselin C, Fortier LC, Ilangumaran S, Menendez A, Ramanathan S. Interleukin 15 in murine models of colitis. Anatomical Record (Hoboken, N.J. : 2007). PMID 35899872 DOI: 10.1002/ar.25044  0.347
2021 Nandi M, Moyo MM, Orkhis S, Mobulakani JMF, Limoges MA, Rexhepi F, Mayhue M, Cayarga AA, Marrero GC, Ilangumaran S, Menendez A, Ramanathan S. IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of . Frontiers in Immunology. 12: 793918. PMID 34956227 DOI: 10.3389/fimmu.2021.793918  0.462
2021 Santharam MA, Shukla A, Ihsan AU, Cloutier M, Levesque D, Ramanathan S, Boisvert FM, Ilangumaran S. SILAC proteomics implicates SOCS1 in modulating cellular macromolecular complexes and the ubiquitin conjugating enzyme UBE2D involved in MET receptor tyrosine kinase downregulation. Biochimie. PMID 33493533 DOI: 10.1016/j.biochi.2021.01.012  0.309
2020 Allard-Chamard H, Mishra HK, Nandi M, Mayhue M, Menendez A, Ilangumaran S, Ramanathan S. Interleukin-15 in autoimmunity. Cytokine. 136: 155258. PMID 32919253 DOI: 10.1016/j.cyto.2020.155258  0.438
2019 Khan MGM, Ghosh A, Variya B, Santharam MA, Kandhi R, Ramanathan S, Ilangumaran S. Hepatocyte growth control by SOCS1 and SOCS3. Cytokine. 121: 154733. PMID 31154249 DOI: 10.1016/j.cyto.2019.154733  0.337
2016 Lacraz G, Rakotoarivelo V, Labbé SM, Vernier M, Noll C, Mayhue M, Stankova J, Schwertani A, Grenier G, Carpentier A, Richard D, Ferbeyre G, Fradette J, Rola-Pleszczynski M, Menendez A, ... ... Ilangumaran S, et al. Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues. Plos One. 11: e0162995. PMID 27684068 DOI: 10.1371/Journal.Pone.0162995  0.351
2016 Rodriguez GM, Bobbala D, Serrano D, Mayhue M, Champagne A, Saucier C, Steimle V, Kufer TA, Menendez A, Ramanathan S, Ilangumaran S. NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes. Oncoimmunology. 5: e1151593. PMID 27471621 DOI: 10.1080/2162402X.2016.1151593  0.343
2016 Bobbala D, Orkhis S, Kandhi R, Ramanathan S, Ilangumaran S. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes. Cytokine. 85: 83-91. PMID 27300756 DOI: 10.1016/j.cyto.2016.06.011  0.55
2016 Chen XL, Serrano D, Ghobadi F, Mayhue M, Hoebe K, Ilangumaran S, Ramanathan S. TCR and IL-7 Signaling Are Altered in the Absence of Functional GTPase of the Immune Associated Nucleotide Binding Protein 5 (GIMAP5). Plos One. 11: e0151837. PMID 27023180 DOI: 10.1371/journal.pone.0151837  0.448
2016 Cepero-Donates Y, Lacraz G, Ghobadi F, Rakotoarivelo V, Orkhis S, Mayhue M, Chen YG, Rola-Pleszczynski M, Menendez A, Ilangumaran S, Ramanathan S. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. Cytokine. PMID 26868085 DOI: 10.1016/j.cyto.2016.01.020  0.392
2016 Bobbala D, Mayhue M, Menendez A, Ilangumaran S, Ramanathan S. Trans-presentation of interleukin-15 by interleukin-15 receptor alpha is dispensable for the pathogenesis of autoimmune type 1 diabetes. Cellular & Molecular Immunology. PMID 26853723 DOI: 10.1038/cmi.2015.102  0.517
2016 Ilangumaran S, Villalobos-Hernandez A, Bobbala D, Ramanathan S. The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions. Cytokine. 82: 125-39. PMID 26822708 DOI: 10.1016/j.cyto.2015.12.013  0.33
2014 Chen XL, Bobbala D, Cepero Donates Y, Mayhue M, Ilangumaran S, Ramanathan S. IL-15 trans-presentation regulates homeostasis of CD4(+) T lymphocytes. Cellular & Molecular Immunology. 11: 387-97. PMID 24658435 DOI: 10.1038/cmi.2014.13  0.588
2014 Gui Y, Yeganeh M, Cepero-Donates Y, Ramanathan S, Saucier C, Ilangumaran S. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma. Current Pharmaceutical Design. 20: 2922-33. PMID 23944359 DOI: 10.2174/13816128113199990597  0.316
2013 Rodriguez GM, D'Urbano D, Bobbala D, Chen XL, Yeganeh M, Ramanathan S, Ilangumaran S. SOCS1 prevents potentially skin-reactive cytotoxic T lymphocytes from gaining the ability to cause inflammatory lesions. The Journal of Investigative Dermatology. 133: 2013-22. PMID 23443260 DOI: 10.1038/jid.2013.86  0.479
2011 Gui Y, Yeganeh M, Ramanathan S, Leblanc C, Pomerleau V, Ferbeyre G, Saucier C, Ilangumaran S. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. Journal of Hepatology. 55: 1300-8. PMID 21703184 DOI: 10.1016/J.Jhep.2011.03.027  0.395
2011 Ramanathan S, Dubois S, Chen XL, Leblanc C, Ohashi PS, Ilangumaran S. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes. Journal of Immunology (Baltimore, Md. : 1950). 186: 5131-41. PMID 21430227 DOI: 10.4049/jimmunol.1001221  0.56
2010 Mallette FA, Calabrese V, Ilangumaran S, Ferbeyre G. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence. Aging. 2: 445-52. PMID 20622265 DOI: v2/n7/full/100163.html  0.314
2010 Ramanathan S, Dubois S, Gagnon J, Leblanc C, Mariathasan S, Ferbeyre G, Rottapel R, Ohashi PS, Ilangumaran S. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens. Journal of Immunology (Baltimore, Md. : 1950). 185: 357-66. PMID 20519645 DOI: 10.4049/Jimmunol.1000066  0.731
2010 Ilangumaran S, Gagnon J, Leblanc C, Poussier P, Ramanathan S. Increased generation of CD8 single positive cells in SOCS1-deficient thymus does not proportionately increase their export. Immunology Letters. 132: 12-7. PMID 20438760 DOI: 10.1016/j.imlet.2010.04.009  0.549
2010 Gagnon J, Chen XL, Forand-Boulerice M, Leblanc C, Raman C, Ramanathan S, Ilangumaran S. Increased antigen responsiveness of naive CD8 T cells exposed to IL-7 and IL-21 is associated with decreased CD5 expression. Immunology and Cell Biology. 88: 451-60. PMID 20065997 DOI: 10.1038/Icb.2009.109  0.573
2009 Ramanathan S, Gagnon J, Dubois S, Forand-Boulerice M, Richter MV, Ilangumaran S. Cytokine synergy in antigen-independent activation and priming of naive CD8+ T lymphocytes. Critical Reviews in Immunology. 29: 219-39. PMID 19538136 DOI: 10.1615/critrevimmunol.v29.i3.30  0.506
2008 Gagnon J, Ramanathan S, Leblanc C, Cloutier A, McDonald PP, Ilangumaran S. IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 180: 7958-68. PMID 18523259  0.539
2007 Chen G, Dimitriou ID, La Rose J, Ilangumaran S, Yeh WC, Doody G, Turner M, Gommerman J, Rottapel R. The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response. Molecular and Cellular Biology. 27: 3109-22. PMID 17283041 DOI: 10.1128/Mcb.01014-06  0.692
2007 Gagnon J, Ramanathan S, Leblanc C, Ilangumaran S. Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8+ T lymphocytes Cellular Signalling. 19: 806-816. PMID 17126530 DOI: 10.1016/j.cellsig.2006.10.003  0.599
2006 Ramanathan S, Gagnon J, Leblanc C, Rottapel R, Ilangumaran S. Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 176: 4029-41. PMID 16547238 DOI: 10.4049/Jimmunol.176.7.4029  0.74
2004 Ilangumaran S, Ramanathan S, Rottapel R. Regulation of the immune system by SOCS family adaptor proteins. Seminars in Immunology. 16: 351-65. PMID 15541651 DOI: 10.1016/J.Smim.2004.08.015  0.64
2003 Ilangumaran S, Finan D, Rottapel R. Flow cytometric analysis of cytokine receptor signal transduction. Journal of Immunological Methods. 278: 221-34. PMID 12957410 DOI: 10.1016/S0022-1759(03)00177-7  0.649
2003 Ilangumaran S, Ramanathan S, La Rose J, Poussier P, Rottapel R. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 171: 2435-45. PMID 12928391 DOI: 10.4049/Jimmunol.171.5.2435  0.783
2003 Ilangumaran S, Finan D, Raine J, Rottapel R. Suppressor of cytokine signaling 1 regulates an endogenous inhibitor of a mast cell protease. The Journal of Biological Chemistry. 278: 41871-80. PMID 12917417 DOI: 10.1074/Jbc.M308382200  0.685
2003 Ilangumaran S, Ramanathan S, Ning T, La Rose J, Reinhart B, Poussier P, Rottapel R. Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes. Blood. 102: 4115-22. PMID 12907450 DOI: 10.1182/Blood-2003-01-0175  0.446
2003 Chan PM, Ilangumaran S, La Rose J, Chakrabartty A, Rottapel R. Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region. Molecular and Cellular Biology. 23: 3067-78. PMID 12697809 DOI: 10.1128/Mcb.23.9.3067-3078.2003  0.528
2003 Ilangumaran S, Rottapel R. Regulation of cytokine receptor signaling by SOCS1. Immunological Reviews. 192: 196-211. PMID 12670405 DOI: 10.1034/J.1600-065X.2003.00020.X  0.658
2002 Ilangumaran S, Finan D, La Rose J, Raine J, Silverstein A, De Sepulveda P, Rottapel R. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts. Journal of Immunology (Baltimore, Md. : 1950). 169: 5010-20. PMID 12391216 DOI: 10.4049/Jimmunol.169.9.5010  0.616
2002 Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P, de Sepulveda P. The tumor suppressor activity of SOCS-1. Oncogene. 21: 4351-62. PMID 12080466 DOI: 10.1038/Sj.Onc.1205537  0.684
Show low-probability matches.